AI assistant
Sending…
Clene Inc. — Director's Dealing 2021
Aug 6, 2021
34487_dirs_2021-08-05_22c52eb1-b168-47fa-81b0-c19943dce7d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2021-08-05
Reporting Person: Ugwumba Chidozie (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-05 | Stock Options (Right to buy) | $9.37 | A | 1766.00 | Acquired | 2031-08-05 | Common Stock (1766.00) | Direct |
Footnotes
F1: This option was granted on August 5, 2021 as an option for 1,766 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant.
More from Clene Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Mar 17
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20